Virogenics Competitors and Similar CompaniesClear all
Accure Therapeutics's competitors and similar companies include Transition Bio.
 Accure Therapeutics Accure Therapeutics is a company that develops a drug candidate portfolio in three programs (ACT-01, ACT-02, ACT-03) pursuing innovative targets that focus on four areas: Optic Neuritis, Multiple Sclerosis, Parkinson’s Disease, and Epilepsy. |  Transition Bio Transition Bio is a biotechnology company that provides technologies for biomolecular condensate analysis. | |
Founding Date | Founding Date 2020 | Founding Date 2020 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Barcelona, ES HQ | Locations Cambridge, US HQ Cambridge, GB |
Employees | Employees N/A | Employees 2915% decrease |
Funding | ||
Latest funding round | Latest funding round $ 8.3m (about 6 years ago) | Latest funding round $ 50m (about 4 years ago) |
Total funding raised | Total funding raised $ 8.3m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Transition Bio
HQ
Cambridge, US
Employees
29↓ 15% decrease
Transition Bio is a biotechnology company that provides technologies for biomolecular condensate analysis.
View company